| P50 | author | Nicola Buckner | Q84762060 |
| | Peter Davies | Q42689763 |
| P2093 | author name string | Su Wu | |
| | Michael L Hutton | |
| | Michael J O'Neill | |
| | Martin Citron | |
| | Claire V Cella | |
| | Tracey K Murray | |
| | Xiyun Chai | |
| | Helen Sims | |
| | Jenna Hanmer | |
| | Robert Kinley | |
| P2860 | cites work | Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia | Q73721145 |
| | Transmission and spreading of tauopathy in transgenic mouse brain | Q24651334 |
| | Active and passive immunotherapy for neurodegenerative disorders | Q24657879 |
| | Tau protein, the paired helical filament and Alzheimer's disease | Q28258279 |
| | Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17 | Q28274687 |
| | Tau suppression in a neurodegenerative mouse model improves memory function | Q29615831 |
| | A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis | Q33720044 |
| | An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice | Q34687145 |
| | Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model | Q35104249 |
| | Tau in cerebrospinal fluid: a sensitive sandwich enzyme-linked immunosorbent assay using tyramide signal amplification | Q35946218 |
| | Laboratory Investigation of Cerebrospinal Fluid Proteins | Q36623870 |
| | Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility | Q39420678 |
| | Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase, Arg. | Q39746633 |
| | Propagation of tau misfolding from the outside to the inside of a cell. | Q39873721 |
| | Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. | Q40090247 |
| | Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease | Q41753192 |
| | Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein | Q42491661 |
| | Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. | Q44205872 |
| | Intracranially Administered Anti-Αβ Antibodies Reduce β-Amyloid Deposition by Mechanisms Both Independent of and Associated with Microglial Activation | Q44433388 |
| | cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. | Q48128979 |
| | Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice | Q48166478 |
| | Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. | Q48217044 |
| | Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies. | Q48392869 |
| | Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein | Q48400266 |
| | Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. | Q53199978 |
| | Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. | Q54613756 |
| P433 | issue | 39 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| | immunization | Q1415366 |
| | passive immunization | Q73525231 |
| P304 | page(s) | 34457-34467 | |
| P577 | publication date | 2011-08-12 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression | |
| P478 | volume | 286 | |